Advanced Therapies/Tirzepatide + B12 (4mL)

Tirzepatide + B12 (4mL)

15 mg / 1 mg · 4 mL Vial

Clinical Access

Clinically Accessed Therapy

This therapy is available exclusively to ROEHN Members and requires asynchronous clinical verification through our licensed telehealth network.

Physician-supervised protocol

Start Online Visit View Membership Options

Format

Injectable / Sublingual

Frequency

See instructions

Overview

A long-acting, dual-incretin metabolic therapy engineered for individuals seeking sustained, clinically meaningful improvements in body composition, appetite control, and metabolic performance. This advanced formulation combines Tirzepatide, a GLP-1 and GIP receptor agonist, with pharmaceutical-grade methylcobalamin (B12) to deliver a powerful synergy of appetite regulation, improved glycemic stability, enhanced insulin sensitivity, and elevated mitochondrial energy. The expanded 4 mL vial offers extended treatment continuity, smoother dose titration, and long-term metabolic optimization—ideal for comprehensive weight-management protocols and ongoing metabolic refinement. Purified, potent, clinically precise. ROEHN’s standard of scientific luxury in metabolic medicine.

Mechanism of Action

GLP-1 Pathway (Semaglutide-Class Activity): • Slows gastric emptying • Enhances satiety signaling • Reduces glucagon output • Supports glucose-responsive insulin secretion GIP Pathway: • Enhances insulinotropic response post-meal • Improves nutrient partitioning • Supports advanced fat metabolism Methylcobalamin (B12): • Fuels mitochondrial energy production • Supports red blood cell formation • Enhances neurological function and mood regulation Together, these mechanisms create a high-efficiency metabolic state, supporting both immediate appetite control and long-term metabolic resilience.

Key Benefits

Dual GLP-1/GIP Incretin Activation: Combines two master metabolic pathways to achieve superior appetite control, enhanced fat metabolism, and deeper glycemic balance compared to single-hormone therapies.

Long-Acting Metabolic Stability: The 4 mL vial supports extended dosing schedules, steady metabolic performance, and fewer fluctuations in hunger, energy, and insulin response.

Advanced Satiety & Craving Suppression: Reduces reward-driven eating, promotes consistent fullness, and supports natural caloric reduction without stimulants.

Improved Glucose Efficiency: Enhances insulin sensitivity, reduces post-meal glucose spikes, and supports balanced daily metabolic activity.

Elevated Energy & Cognitive Clarity (B12): Methylcobalamin supports neurological performance, mitochondrial ATP production, and consistent, non-stimulant energy.

Sustainable, Clinically Backed Weight Reduction: Shown to reduce body weight, improve waist circumference, and enhance overall metabolic health when paired with lifestyle alignment.

Suggested Use

Administered in weekly microdoses according to clinical guidance. Most individuals experience earlier satiety and reduced cravings within the first 1–2 weeks, with significant body-composition improvements developing over the following months. The 4 mL vial offers extended usage, smoother titration, and greater dosing continuity.